Resources

  Konstantinos Makrilakis, MD, PhD Nikolaos Katsilambros, MD, PhD.     Hyperosmolar non-ketotic hyperglycemia (also called hyperosmolar hyperglycemic state [HHS]) is one of the most serious acute complications of diabetes, with significant morbidity and mortality.

      By Sheri Colberg, PhD   Individuals with all types of diabetes frequently are deconditioned and live a sedentary lifestyle.

Invokana® (canagliflozin) The FDA has approved the first-in-class sodium glucose cotransporter 2 (SGLT2) inhibitor, canagliflozin. Find out all about this new drug — mode of action, contraindications, side effects, weight loss, lower A1c’s, blood pressure and its effect on cholesterol — with this handout for medical professionals. Just follow this …

The FDA has approved Invokana (canaglifozin), the first in its class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. Johnson & Johnson’s new drug is used to treat type 2 diabetes in conjunction with diet and exercise….

Worms treated with metformin live longer. The drug may slow the aging process by mimicking the effects of dieting….

An increase in dietary fat can raise glucose levels and insulin requirements in patients with type 1 diabetes….

Metformin delays aging and cancer progression by reducing the production of….

Marijuana used regularly has little impact on the overall metabolism of glucose and lipids….

A study focused on social networking and support groups showed the effects of these programs on blood sugar levels are short-term….

Study shows type 1 diabetes patients do not need to adjust their flexible insulin scale based on the amount of protein they are about to consume….